8IF7 image
Deposition Date 2023-02-17
Release Date 2023-07-26
Last Version Date 2024-10-23
Entry Detail
PDB ID:
8IF7
Title:
Crystal structure of CmnB
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 43
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CmnB
Gene (Uniprot):cmnB
Chain IDs:A
Chain Length:383
Number of Molecules:1
Biological Source:Saccharothrix mutabilis subsp. capreolus
Ligand Molecules
Primary Citation
Crystal structure of CmnB involved in the biosynthesis of the nonproteinogenic amino acid L-2,3-diaminopropionic acid.
Acta Crystallogr.,Sect.F 79 193 199 (2023)
PMID: 37405487 DOI: 10.1107/S2053230X23005769

Abstact

L-2,3-Diaminopropionic acid (L-Dap) is a nonproteinogenic amino acid that plays as an important role as a building block in the biosynthesis of several natural products, including capreomycin, viomycin, zwittermicin, staphyloferrin and dapdiamide. A previous study reported that CmnB and CmnK are two enzymes that are involved in the formation of L-Dap in the biosynthesis of capreomycin. CmnB catalyzes the condensation reaction of O-phospho-L-serine and L-glutamic acid to generate N-(1-amino-1-carboxyl-2-ethyl)glutamic acid, which subsequently undergoes oxidative hydrolysis via CmnK to generate the product L-Dap. Here, the crystal structure of CmnB in complex with the reaction intermediate PLP-α-aminoacrylate is reported at 2.2 Å resolution. Notably, CmnB is the second known example of a PLP-dependent enzyme that forms a monomeric structure in crystal packing. The crystal structure of CmnB also provides insights into the catalytic mechanism of the enzyme and supports the biosynthetic pathway of L-Dap reported in previous studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures